Drugs against articular failure

a technology for articular failure and drugs, applied in the direction of drug compositions, chewing gum, biocide, etc., can solve the problems of increasing the crisis rate of articular disorders, articular disorders becoming a social problem, and exposure to risks such as inflammation and physical destruction, and achieve satisfying taste and flavor

Inactive Publication Date: 2004-02-26
HAYASHIBARA BIOCHEMICAL LAB INC
View PDF7 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

0005] In view of the above backgrounds, the object of the present invention is to provide an agent for treating articular disorders, which exerts an effect of recover

Problems solved by technology

Articulations in mammals including humans are mechanically stimulated during their physical activities and exposed to risks such as inflammation and physical destruction.
It has been pointed out that the crisis rate of articular disorders increases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 2

Agent For Treating Articular Disorders

[0049] Three and half parts by weight of crystalline hydrous trehalose ("TREHA.RTM.", commercialized by Hayashibara Shoji Inc., Okayama, Japan), one part by weight of glucosamine ("NATURAL GLUCOSAMINE.TM.", commercialized by Yaizu Suisankagaku Industry Co., Ltd., Shizuoka, Japan) and 0.5 part by weight of chondroitin 4-sulfate ("MUCOTEIN-DK.TM.", commercialized by Yaizu Suisankagaku Industry Co., Ltd., Shizuoka, Japan) were mixed well to obtain the captioned product in the form of a powder.

[0050] Since the product remarkably exerts an action on articular disorders and has mild sweetness, it is useful to prevent or alleviate articular disorder such as arthritis and rheumatoid as a health food. The product can be used as a health food in the form of a tablet produced by a conventional tableting method, and it can be also used in foods, cosmetics and pharmaceuticals as an additive for imparting or supplementing the action for articular disorders.

example 3

Agent For Treating Articular Disorders

[0051] Four parts by weight of crystalline hydrous trehalose ("TREHA.RTM.", commercialized by Hayashibara Shoji Inc., Okayama, Japan), one part by weight of N-acetylglucosamine ("MARINE SWEET.TM.", commercialized by Yaizu Suisankagaku Industry Co., Ltd., Shizuoka, Japan), 0.5 part by weight of chondroitin 4-sulfate ("MUCOTEIN-DK.TM.", commercialized by Yaizu Suisankagaku Industry Co., Ltd.) and 0.1 part by weight of 2-O-alpha-D-glucopyranosyl L-ascorbic acid ("AA-2G.RTM.", commercialized by Hayashibara Shoji Inc., Okayama, Japan) were mixed well to obtain the captioned product in a powder form.

[0052] Since the product remarkably exerts the action for treating articular disorders and has mild sweetness, it is useful to prevent or alleviate articular disorder such as arthritis and rheumatoid as a health food. The product can be used as a health food in the form of a tablet produced by a conventional tableting method, and it can be also used in foo...

example 4

Agent For Treating Articular Disorders

[0053] Five hundreds fifty parts by weight of fine powdery crystalline hydrous aluminum silicate, 50 parts by weight of boric acid, 400 parts by weight of condense glycerin, four parts by weight of camphor, 0.5 parts by weight of peppermint oil, 10 parts by weight of crystalline anhydrous maltitol ("MABIT.RTM." (granule type), commercialized by Hayashibara Shoji Inc., Okayama, Japan) and 60 parts by weight of the agent for treating articular disorders of Example 1 were placed in a heat-resistant vessel and mixed well in a hot water bath to obtain the captioned product in a gel form.

[0054] Since the product can be used by attaching to the skin similarly as in conventional hot cataplasms, it can be used as a cataplasm to prevent or cure articulation disorders in various fields of pharmaceuticals, etc.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Dimensionless propertyaaaaaaaaaa
Timeaaaaaaaaaa
Timeaaaaaaaaaa
Login to view more

Abstract

The object of the present invention is to provide a composition which exerts a higher effect on recovering health from articular disorders than that attained by amino sugars and glycosaminoglycans. The present invention solves the object by providing an agent for treating articular disorders, comprising an amino sugar and trehalose as effective ingredients.

Description

[0001] The present invention relates to a novel agent for treating articular disorders, more particularly, to the agent which comprises an amino sugar and trehalose as effective ingredients.[0002] Articulations in mammals including humans are mechanically stimulated during their physical activities and exposed to risks such as inflammation and physical destruction. Examples of factors of causing disorders in articulations (hereinafter, briefly called "articular disorders") are infections, injuries, allergies, metabolic disorders, corpulences, and blood circulation disorders. It has been pointed out that the crisis rate of articular disorders increases as aging, and articular disorders are becoming to be a social problem in this aging society.[0003] As articular disorders generally accompany inflammations, they are treated with anti-inflammatories in many cases. However, treatments thereof can be only effective for temporarily suppressing some symptoms accompanied by articular disord...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A23G4/00A23G4/10A23L1/09A23L1/30A23L2/52A23L33/00A61K8/00A61K8/60A61K8/72A61K8/73A61K31/7008A61K31/7016A61K31/726A61K31/727A61K31/728A61K31/737A61P19/02A61P29/00A61P29/02A61P43/00A61Q19/10
CPCA23G4/10A23L1/09A61Q19/10A61K2800/59A61K31/728A61K31/727A61K31/7016A61K31/7008A61K8/735A23L1/296A23L1/30A23L2/52A61K8/60A61K2300/00A23L5/00A23L29/30A23L33/10A23L33/125A23L33/40A61P19/02A61P29/00A61P29/02A61P43/00
Inventor FUKUDA, SHIGEHARUARIO, TAKESHIMIYAKE, TOSHIO
Owner HAYASHIBARA BIOCHEMICAL LAB INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap